CARING AMBASSADORS

Empowering People to be Ambassadors of their Own Health Since 1997.

LUNG CANCER PROGRAM


Monthly Pubmed Review

Monthly Pubmed Review of the Most Relevant Research on Lung Cancer
Literature Review, January 2015

BASIC AND APPLIED SCIENCE, PRE-CLINICAL STUDIES

Effect of Single Nucleotide Polymorphism Rs189037 in ATM Gene on Risk of Lung Cancer in Chinese: A Case-Control Study. Liu J1, Wang X1, Ren Y2, Li X2, Zhang X2, Zhou B2. PLoS One. 2014 Dec 26;9(12):e115845. doi: 10.1371/journal.pone.0115845. eCollection 2014.

Combined treatment of XIAP-targeting shRNA and celecoxib synergistically inhibits the tumor growth of non small cell lung cancer cells in vitro and in vivo. Zhang H1, Li Z1, Wang K1, Ren P1. Oncol Rep. 2014 Dec 18. doi: 10.3892/or.2014.3678. [Epub ahead of print]

GM2-Activator Protein: A New Biomarker for Lung Cancer. Potprommanee L1, Ma HT, Shank L, Juan YH, Liao WY, Chen ST, Yu CJ. J Thorac Oncol. 2014 Dec 8. [Epub ahead of print]

MET amplification status in therapy-naïve adeno- and squamous cell carcinomas of the lung. Schildhaus H1, Schultheis AM2, Ruschoff J3, et al. Clin Cancer Res. 2014 Dec 9. pii: clincanres.0450.2014. [Epub ahead of print]

Genetic polymorphisms in the vitamin D pathway in relation to lung cancer risk and survival. Kong J1, Xu F2, Qu J2, Wang Y2, Gao M2, Yu H3, Qian B4. Oncotarget. 2014 Dec 10. [Epub ahead of print]

Molecular Pathways: Targeting NRG1 Fusions in Lung Cancer. Fernandez-Cuesta L1, Thomas RK2. Clin Cancer Res. 2014 Dec 11. pii: clincanres.0854.2014. [Epub ahead of print]

Early recognition of lung cancer by integrin targeted imaging in K-ras mouse model. Ermolayev V1, Mohajerani P, Ale A, et al. Int J Cancer. 2014 Dec 2. doi: 10.1002/ijc.29372. [Epub ahead of print]

Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma. Zhao M1, Zhang Y2, Zhang H3, et al. Lung Cancer. 2014 Dec 3. pii: S0169-5002(14)00490-5. doi: 10.1016/j.lungcan.2014.11.017. [Epub ahead of print]

Role of LKB1-CRTC1 on Glycosylated COX-2 and Response to COX-2 Inhibition in Lung Cancer. Cao C1, Gao R1, Zhang M1, et al. J Natl Cancer Inst. 2014 Dec 1;107(1). pii: dju358. doi: 10.1093/jnci/dju358. Print 2015 Jan.

Identification of a novel HIP1-ALK fusion variant in Non-Small-Cell Lung Cancer (NSCLC) and discovery of ALK I1171 (I1171N/S) mutations in two ALK-rearranged NSCLC patients with resistance to Alectinib. Ou SH1, Klempner SJ, Greenbowe JR, et al. J Thorac Oncol. 2014 Dec;9(12):1821-5. doi: 10.1097/JTO.0000000000000368.

Effects of estrogen-related receptor alpha (ERRα) on proliferation and metastasis of human lung cancer A549 cells. Huang JW1, Guan BZ, Yin LH, Liu FN, Hu B, Zheng QY, Li FL, Zhong YX, Chen Y. J Huazhong Univ Sci Technolog Med Sci. 2014 Dec;34(6):875-81. doi: 10.1007/s11596-014-1367-0. Epub 2014 Dec 6.

Kinome sequencing reveals RET G691S polymorphism in human neuroendocrine lung cancer cell lines. Sosonkina N1, Hong S1, Starenki D1, Park J1. Genes Genomics. 2014 Dec;36(6):829-841.

Loss of 4q21.23-22.1 is a prognostic marker for disease free and overall survival in non-small cell lung cancer.  Uzunoglu FG1, Dethlefsen E2, Hanssen A2, et al. PLoS One. 2014 Dec 11;9(12):e113315. doi: 10.1371/journal.pone.0113315. eCollection 2014.

SCREENING, DIAGNOSIS AND STAGING

The importance of lung cancer screening with low-dose computed tomography for Medicare beneficiaries. Wood DE1. JAMA Intern Med. 2014 Dec 1;174(12):2016-8. doi: 10.1001/jamainternmed.2014.5623.

Perception of lung cancer among the general population and comparison with other cancers. Mazières J1, Pujol JL, Kalampalikis N, et al. J Thorac Oncol. 2014 Dec 15. [Epub ahead of print]

Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non-small cell lung cancer: A comparison of Ventana immunohistochemistry and fluorescence in situ hybridization. Wang W1, Tang Y, Li J, Jiang L, Jiang Y, Su X. Cancer Cytopathol. 2014 Dec 19. doi: 10.1002/cncy.21510. [Epub ahead of print]

Limitations of 18F-2-Deoxy-d-Glucose Positron Emission Tomography in N1 Detection in Patients With Pathologic Stage II-N1 and Implications for Management. Kim MP1, Correa AM2, Hofstetter W2, Mehran R2, Rice DC2, Roth JA2, Vaporciyan AA2, Walsh GL2, Erasmus JJ3, Swisher SG4.

A point-of-care testing system with Love-wave sensor and immunogold staining enhancement for early detection of lung cancer. Zou Y1, Zhang X, An C, Ran C, Ying K, Wang P. Biomed

Regulatory T-Cells and Micrometastasis in Lymph Nodes of Stage I NSCLC. Hanagiri T1, Fukumoto M2, Koyanagi Y2, Furutani Y2, Tanaka F2. Anticancer Res. 2014 Dec;34(12):7185-90.

Geographic variation in cancer-related imaging: Veterans Affairs health care system versus Medicare. McWilliams JM, Dalton JB, Landrum MB, Frakt AB, Pizer SD, Keating NL. Ann Intern Med. 2014 Dec 2;161(11):794-802. doi: 10.7326/M14-0650.

 Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of nonsmall cell lung cancer. Lozano MD1, Labiano T, Echeveste J, Gurpide A, Martín-Algarra S, Zhang G, Sharma A, Palma JF. Cancer Cytopathol. 2014 Dec 19. doi: 10.1002/cncy.21513. [Epub ahead of print]

Computed Tomography Screening for Lung Cancer: Preliminary Results in a Diverse Urban Population. Milch H1, Kaminetzky M, Pak P, Godelman A, Shmukler A, Koenigsberg TC, Haramati LB. J Thorac Imaging. 2014 Dec 19. [Epub ahead of print]

 A comprehensive investigation of molecular features and prognosis of lung adenocarcinoma with micropapillary component. Zhang Y1, Wang R, Cai D, et al. J Thorac Oncol. 2014 Dec;9(12):1772-8. doi: 10.1097/JTO.0000000000000341.

CLINICAL TRIALS, COHORT STUDIES, PILOT STUDIES – NSCLC – SURGERY

Patient educational needs of patients undergoing surgery for lung cancer. King J1, Chamberland P, Rawji A, et al. J Cancer Educ. 2014 Dec;29(4):802-7. doi: 10.1007/s13187-014-0658-2.

Inflammation-based scoring is a useful prognostic predictor of pulmonary resection for elderly patients with clinical stage I non-small-cell lung cancer. Miyazaki T1, Yamasaki N2, Tsuchiya T2, et al. Eur J Cardiothorac Surg. 2014 Dec 29. pii: ezu514. [Epub ahead of print]

VATS Lobectomy Has Better Perioperative Outcomes Than Open Lobectomy: CALGB 31001, an Ancillary Analysis of CALGB 140202 (Alliance). Nwogu CE1, D’Cunha J2, Pang H3, et al. Ann Thorac Surg. 2014 Dec 10. pii: S0003-4975(14)01830-X. doi: 10.1016/j.athoracsur.2014.09.018. [Epub ahead of print]

Does Previous Surgical Training Impact the Learning Curve in Video-Assisted Thoracic Surgery Lobectomy for Trainees? Billè A1, Okiror L2, Harrison-Phipps K2, Routledge T2. Thorac Cardiovasc Surg. 2014 Dec 2. [Epub ahead of print]

Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. Shirvani SM1, Jiang J2, Chang JY3, et al. JAMA Surg. 2014 Dec 1;149(12):1244-53. doi: 10.1001/jamasurg.2014.556.

Audit of Lymphadenectomy in Lung Cancer Resections Using a Specimen Collection Kit and Checklist. Osarogiagbon RU1, Sareen S2, Eke R3, Yu X3, McHugh LM2, Kernstine KH4, Putnam JB5, Robbins ET2. Ann Thorac Surg. 2014 Dec 19. pii: S0003-4975(14)01917-1. doi: 10.1016/j.athoracsur.2014.09.049. [Epub ahead of print]

CLINICAL TRIALS, COHORT STUDIES, PILOT STUDIES – NSCLC – CHEMOTHERAPY

Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer. Novello S1, Kaiser R2, Mellemgaard A3, et al. Eur J Cancer. 2014 Dec 17. pii: S0959-8049(14)01139-3. doi: 10.1016/j.ejca.2014.11.015. [Epub ahead of print]

Efficacy of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Patients with/without EGFR-Mutation: Evidence Based on Recent Phase III Randomized Trials. Zhang WQ1, Li T1, Li H1. Med Sci Monit. 2014 Dec 15;20:2666-76. doi: 10.12659/MSM.892476.

Alectinib Salvages CNS Metastases in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib. Gainor JF1, Sherman CA, Willoughby K, et al. J Thorac Oncol. 2014 Dec 18. [Epub ahead of print]

Phase II trial of recombinant human endostatin in combination with concurrent chemo-radiotherapy in patients with stage III non-small-cell lung cancer. Bao Y1, Peng F2, Zhou QC3, et al. Radiother Oncol. 2014 Dec 9. pii: S0167-8140(14)00544-1. doi: 10.1016/j.radonc.2014.11.039. [Epub ahead of print]

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small cell lung cancer. Chiappori AA1, Kolevska T2, Spigel DR3, et al. Ann Oncol. 2014 Dec 2. pii: mdu550. [Epub ahead of print]

First-line crizotinib versus chemotherapy in ALK-positive lung cancer. Solomon BJ1, Mok T, Kim DW, et al. N Engl J Med. 2014 Dec 4;371(23):2167-77. doi: 10.1056/NEJMoa1408440.

Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial. Vrankar M1, Zwitter M2, Bavcar T3, Milic A1, Kovac V1. Radiol Oncol. 2014 Nov 5;48(4):369-80. eCollection 2014.

An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity. Minchom AR1, Saksornchai K1, Bhosle J1, et al. BMJ Open Respir Res. 2014 Dec 11;1(1):e000061. doi: 10.1136/bmjresp-2014-000061. eCollection 2014.

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer. Karim NA1, Bui H2, Pathrose P3, Starnes S3, Patil N4, Shehata M1, Mostafa A5, Rao M6, Zarzour A7, Anderson M8. Clin Med Insights Oncol. 2014 Dec 7;8:139-44. doi: 10.4137/CMO.S18369. eCollection 2014.

Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Patients With Biomarker-Selected Non-Small-Cell Lung Cancer. Edelman MJ1, Tan MT2, Fidler MJ2, et al. J Clin Oncol. 2014 Dec 1. pii: JCO.2014.55.5789. [Epub ahead of print]

Dose Escalation and Pharmacokinetic Study of Carboplatin plus Pemetrexed for Elderly Patients with Advanced Nonsquamous Non-Small-Cell Lung Cancer: Kumamoto Thoracic Oncology Study Group Trial 1002. Sakata S1, Sasaki J, Saeki S, et al. Oncology. 2014 Dec 6;88(4):201-207. [Epub ahead of print]

Final overall survival results from a phase III, randomised, placebo-controlled, parallel-group study of gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804). Zhao H1, Fan Y, Ma S, et al. J Thorac Oncol. 2014 Dec 24. [Epub ahead of print]

CLINICAL TRIALS, COHORT STUDIES, PILOT STUDIES – NSCLC – RADIOTHERAPY

Four Dimensional Digital Tomosynthesis Using on-Board Imager for the Verification of Respiratory Motion. Park JC1, Kim JS2, Park SH3, Webster MJ4, Lee S1, Song WY5, Han Y2. PLoS One. 2014 Dec 26;9(12):e115795. doi: 10.1371/journal.pone.0115795. eCollection 2014.

Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer. Miura H1, Inoue T2, Shiomi H2, Oh RJ2. J Radiat Res. 2014 Dec 11. pii: rru107. [Epub ahead of print]

Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trial. Hoover DA, Capaldi DP, Sheikh K, et al. BMC Cancer. 2014 Dec 11;14(1):934. [Epub ahead of print]

Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Non-Small-Cell Lung Cancer: What We Have Learned on behalf of the IASLC Advanced Radiation Technology Committee.  Chang JY1, Bezjak A, Mornex F; On behalf of the IASLC Advanced Radiation Technology Committee. J Thorac Oncol. 2014 Dec 15. [Epub ahead of print]

Patients with severe emphysema have a low risk of radiation pneumonitis following stereotactic body radiotherapy. Ishijima M1, Nakayama H, Itonaga T, et al. Br J Radiol. 2014 Dec 9:20140596. [Epub ahead of print]

Comparative effectiveness of intensity-modulated versus 3D conformal radiation therapy among medicare patients with stage III lung cancer. Chen AB1, Li L, Cronin A, Schrag D. J Thorac Oncol. 2014 Dec;9(12):1788-95. doi: 10.1097/JTO.0000000000000331.

Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy. Podder T1, Biswas T, Yao M, Zhang Y, Kim E, Ellis RJ, Lo SS, Machtay M. Future Oncol. 2014 Dec;10(15):2311-7. doi: 10.2217/fon.14.158.

Using an external surrogate for predictor model training in real-time motion management of lung tumors. Rottmann J1, Berbeco R1. Med Phys. 2014 Dec;41(12):121706. doi: 10.1118/1.4901252.

Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer. Rades D1, Huttenlocher S, Hornung D, Blanck O, Schild SE. BMC Cancer. 2014 Dec 11;14:931. doi: 10.1186/1471-2407-14-931.

Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 non-small-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy. Li N1, Zeng ZF2, Wang SY3, et al. Ann Oncol. 2014 Dec 15. pii: mdu567. [Epub ahead of print]

 

CLINICAL TRIALS, COHORT STUDIES, PILOT STUDIES – NSCLC – OTHER

CLINICAL TRIALS, COHORT STUDIES, PILOT STUDIES – SMALL CELL LUNG CANCER (SCLC)

Phase 2 Study of Accelerated Hypofractionated Thoracic Radiation Therapy and Concurrent Chemotherapy in Patients With Limited-Stage Small-Cell Lung Cancer. Xia B1, Hong LZ2, Cai XW3, et al. Int J Radiat Oncol Biol Phys. 2014 Dec 3. pii: S0360-3016(14)04195-9. doi: 10.1016/j.ijrobp.2014.09.042. [Epub ahead of print]

Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor. Christensen CL1, Kwiatkowski N2, Abraham BJ2, et al. Cancer Cell. 2014 Dec 8;26(6):909-22. doi: 10.1016/j.ccell.2014.10.019.

Feasibility and efficacy of simultaneous integrated boost intensity-modulated radiation therapy in patients with limited-disease small cell lung cancer. Han D, Qin Q, Hao S, Huang W, Wei Y, Zhang Z, Wang Z, Li B. Radiat Oncol. 2014 Dec 11;9(1):280. [Epub ahead of print]

The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients. Hong S1, Zhou T, Fang W, et al. Tumour Biol. 2014 Dec 20. [Epub ahead of print]

Correlation of Dosimetric and Clinical Factors With the Development of Esophagitis and Radiation Pneumonitis in Patients With Limited-Stage Small-Cell Lung Carcinoma. Giuliani ME1, Lindsay PE2, Kwan JY2, et al. Clin Lung Cancer. 2014 Dec 2. pii: S1525-7304(14)00244-7. doi: 10.1016/j.cllc.2014.11.008. [Epub ahead of print]

Comparison of Two Dose Levels of Stereotactic Radiosurgery for 1-3 Brain Metastases from Non-small Cell Lung Cancer. Rades D1, Huttenlocher S2, Dahlke M2, et al. Anticancer Res. 2014 Dec;34(12):7309-13.

Prophylactic cranial irradiation in elderly patients with small cell lung cancer: Findings from a North Central Cancer Treatment Group pooled analysis. Rule WG1, Foster NR2, Meyers JP2, et al. J Geriatr Oncol. 2014 Dec 4. pii: S1879-4068(14)00355-5. doi: 10.1016/j.jgo.2014.11.002. [Epub ahead of print]

HRCT findings of small cell lung cancer measuring 30 mm or less located in the peripheral lung. Kobayashi T1, Tanaka N, Matsumoto T, et al. Jpn J Radiol. 2014 Dec 16. [Epub ahead of print]

The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients. Hong S1, Zhou T, Fang W, et al. Tumour Biol. 2014 Dec 20. [Epub ahead of print]

PALLIATIVE AND SUPPORTIVE CARE

Engaging patients and caregivers in patient-centered outcomes research on advanced stage lung cancer: insights from patients, caregivers, and providers. Islam KM1, Opoku ST, Apenteng BA, et al. J Cancer Educ. 2014 Dec;29(4):796-801. doi: 10.1007/s13187-014-0657-3.

Assessment of National Practice for Palliative Radiation Therapy for Bone Metastases Suggests Marked Underutilization of Single-Fraction Regimens in the United States. Rutter CE1, Yu JB2, Wilson LD2, Park HS2. Int J Radiat Oncol Biol Phys. 2014 Dec 24. pii: S0360-3016(14)04351-X. doi: 10.1016/j.ijrobp.2014.10.045. [Epub ahead of print]

‘Getting back to normal’ or ‘a new type of normal’? A qualitative study of patients’ responses to the existential threat of cancer. Baker P1, Beesley H, Fletcher I, Ablett J, Holcombe C, Salmon P. Eur J Cancer Care (Engl). 2014 Dec 19. doi: 10.1111/ecc.12274. [Epub ahead of print]

Quality of life in very elderly radiotherapy patients: a prospective pilot study using the EORTC QLQ-ELD14 module. Kaufmann A1, Schmidt H, Ostheimer C, Ullrich J, Landenberger M, Vordermark D. Support Care Cancer. 2014 Dec 6. [Epub ahead of print]

Palliative radiotherapy for bone metastases from lung cancer: Evidence-based medicine? Fairchild A1. World J Clin Oncol. 2014 Dec 10;5(5):845-57. doi: 10.5306/wjco.v5.i5.845.

Randomised controlled trial on the effectiveness of home-based walking exercise on anxiety, depression and cancer-related symptoms in patients with lung cancer. Chen HM1, Tsai CM2, Wu YC3, Lin KC4, Lin CC5. Br J Cancer. 2014 Dec 9. doi: 10.1038/bjc.2014.612. [Epub ahead of print]

Estimating the Need for Palliative Radiotherapy for Brain Metastasis: A Benchmarking Approach. Kong W1, Jarvis C1, Mackillop WJ2. Clin Oncol (R Coll Radiol). 2014 Dec 3. pii: S0936-6555(14)00412-9. doi: 10.1016/j.clon.2014.11.001. [Epub ahead of print]

Melatonin in Patients with Cancer Receiving Chemotherapy: A Randomized, Double-blind, Placebo-controlled Trial. Sookprasert A1, Johns NP2, Phunmanee A1, et al. Anticancer Res. 2014 Dec;34(12):7327-37.

Population-Based Assessment of Cancer Survivors’ Financial Burden and Quality of Life: A Prospective Cohort Study. Zafar SY1, McNeil RB2, Thomas CM2, Lathan CS2, Ayanian JZ2, Provenzale D2. J Oncol Pract. 2014 Dec 16. pii: JOP.2014.001542. [Epub ahead of print]

Coping with physical and psychological symptoms: a qualitative study of advanced lung cancer patients and their family caregivers. Mosher CE1, Ott MA, Hanna N, Jalal SI, Champion VL. Support Care Cancer. 2014 Dec 20. [Epub ahead of print]

COMPLEMENTARY & ALTERNATIVE THERAPY

Chemical Composition and Anti-Inflammatory, Cytotoxic and Antioxidant Activities of Essential Oil from Leaves of Mentha piperita Grown in China. Sun Z1, Wang H2, Wang J3, Zhou L3, Yang P1. PLoS One. 2014 Dec 10;9(12):e114767. doi: 10.1371/journal.pone.0114767. eCollection 2014.

Effects of Kuan-Sin-Yin decoction on immunomodulation and tumorigenesis in mouse tumor models. Li TF, Lin CC, Tsai HP, Hsu CH1, Fu SL. BMC Complement Altern Med. 2014 Dec 15;14:488. doi: 10.1186/1472-6882-14-488.

Alkaloid extracts of Ficus species and palm oil-derived tocotrienols synergistically inhibit proliferation of human cancer cells. Abubakar IB1, Lim KH, Loh HS. Nat Prod Res. 2014 Dec 17:1-4. [Epub ahead of print]

Antitumor progression potential of morusin suppressing STAT3 and NFκB in human hepatoma SK-Hep1 cells. Lin W1, Lai D2, Lee Y3, Chen N4, Tseng T5. Toxicol Lett. 2014 Dec 2;232(2):490-498. doi: 10.1016/j.toxlet.2014.11.031. [Epub ahead of print]

MISCELLANEOUS WORKS

Long-term trends in adult mortality for u.s. Blacks and whites: an examination of period- and cohort-based changes. Masters RK1, Hummer RA, Powers DA, Beck A, Lin SF, Finch BK. Demography. 2014 Dec;51(6):2047-73. doi: 10.1007/s13524-014-0343-4.

High proportion of rare and compound epidermal growth factor receptor mutations in an Australian population of non-squamous non-small-cell lung cancer. Stone E1, Allen HA, Saghaie T, et al. Intern Med J. 2014 Dec;44(12a):1188-92. doi: 10.1111/imj.12587.

Implementation of New Clinical Programs in the VHA Healthcare System: The Importance of Early Collaboration Between Clinical Leadership and Research. Wu RR1, Kinsinger LS, Provenzale D, et al. J Gen Intern Med. 2014 Dec;29 Suppl 4:825-30. doi: 10.1007/s11606-014-3026-3.

An evaluation of the impact of large-scale interventions to raise public awareness of a lung cancer symptom. Ironmonger L1, Ohuma E1, Ormiston-Smith N1, Gildea C2, Thomson CS3, Peake MD4. Br J Cancer. 2014 Dec 2. doi: 10.1038/bjc.2014.596. [Epub ahead of print]

Improving interprofessional collaboration: Evaluation of implicit attitudes in the surgeon-nurse relationship. Braun HJ1, O’Sullivan PS2, Dusch MN1, Antrum S3, Ascher NL4. Int J Surg. 2014 Dec 12;13C:175-179. doi: 10.1016/j.ijsu.2014.11.032. [Epub ahead of print]

Oncologists’ Experiences With Drug Shortages. Kehl KL1, Gray SW1, Kim B1, et al. J Oncol Pract. 2014 Dec 30. pii: JOP.2014.000380. [Epub ahead of print]

Receipt of Chemotherapy Among Medicare Patients With Cancer by Type of Supplemental Insurance. Warren JL1, Butler EN2, Stevens J2, Lathan CS2, Noone A2, Ward KC2, Harlan LC2. J Clin Oncol. 2014 Dec 22. pii: JCO.2014.55.3107. [Epub ahead of print]

Caring Ambassadors Program, Inc. | P.O. Box 1748 | Oregon City, OR 97045 | 503-632-9032 | 503-632-9038 (Fax)